NCT05914883Active, not recruiting
The NORwegian Atrial Fibrillation Self-SCREENing
Source: ClinicalTrials.gov · Last updated 29 Jul 2025
Brief summary (registry, in English)
Atrial fibrillation (AF) is common, increases the risk of mortality, stroke and heart failure, and portending significant burden to patients, societal health and health economy. One of three AF cases are undiagnosed. Several methods for detection of AF exist, but most of them have major limitations and are associated with resource-demanding diagnostic workup in the speciality health care services.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 50000 (actual)
- First submitted
- 8 Jun 2023
- Start date
- 1 Sept 2023
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Oslo University Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT05914883
What you commit to
- Study type: Interventional
- Participants enrolled: 50000
- From 1 Sept 2023 to the primary completion date, 31 Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of anticoagulation therapy
Other illness
- History of AF (self-reported)
Other
- Pacemaker/CRT device
- No smart phone
Who the study is looking for
- Age ≥65 years and minimum one other risk factor for stroke according to the CHA2DS2-VASc risk score: Age ≥75 years, Diabetes, Heart failure, Hypertension, Previous stroke/TIA and/or Vascular disease
- Informed consent for participation
Age in the registry: 65 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oslo Unvirsity Hospital Coordinator of this site? Confirm its status | Oslo | Norway | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.